You are here

Sandoz

EQT, Biontech investor family consider Sandoz bid

Yahoo/Reuters

Fri, 11/19/21 - 11:12 am

Swiss socialists say government should buy Sandoz

Pharmaforum

Mon, 11/8/21 - 10:38 am

What Novartis could buy with its windfall

EP Vantage

Fri, 11/5/21 - 09:40 am

Aurinia Pharmaceuticals

Novartis looking into future of its Sandoz’ generics business

Pharmaforum

Tue, 10/26/21 - 10:30 am

Three generic firms shell out $447M more to settle federal price fixing allegations

Endpoints

Mon, 10/4/21 - 10:59 am

Taro Pharmaceuticals

Amgen scores Otezla patent win, protecting its blockbuster from Sandoz and Zydus generics until 2028

Fierce Pharma

Tue, 09/21/21 - 10:54 am

market exclusivity

Sandoz in oncology biosimilar deal with China’s Bio-Thera

Biopharma Reporter

Wed, 09/8/21 - 11:15 am

Bio-Thera Solutions

Novartis' Sandoz embarks on €150M antibiotics manufacturing upgrade in Europe

Fierce Pharma

Tue, 05/18/21 - 11:01 am

drug manufacturing

Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free rein

Fierce Pharma

Mon, 05/17/21 - 10:59 pm

Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity

Endpoints

Tue, 03/9/21 - 10:49 am

multiple sclerosis

GlaxoSmithKline to shut down antibiotics production, cut 300 jobs in wake of Novartis buyout

Fierce Pharma

Fri, 02/12/21 - 11:09 am

drug manufacturing

Novartis' Sandoz doubles down on antibiotics with $500M deal for GSK brands

Fierce Pharma

Thu, 02/11/21 - 10:26 pm

Sandoz working to overcome barriers to greater biosimilars uptake in US

Biopharma Reporter

Mon, 09/21/20 - 10:55 am

Sandoz earmarks $175M to upgrade tech at European hub for antibiotics manufacturing

BioPharma Dive

Mon, 07/27/20 - 11:05 pm

drug manufacturing

Novartis to provide 'no profit' COVID-19 drugs to low income countries

Reuters

Thu, 07/16/20 - 11:00 am

developing countries

Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report

Fierce Pharma

Mon, 05/18/20 - 10:56 pm

Teva Pharmaceutical

Taro Pharmaceuticals

Novartis cancels $1B sale of generics after antitrust concerns forced delays

Endpoints

Thu, 04/2/20 - 10:49 am

Sandoz Pays $195 Million to Settle Criminal Antitrust Charges in Sweeping Federal Probe

BioSpace

Tue, 03/3/20 - 10:55 am

Sandoz pledges 'stable' pricing for generics, antibiotics amid COVID-19 supply chain worries

Fierce Pharma

Thu, 02/27/20 - 10:39 am

Former Novartis exec pleads guilty to generic price fixing

Endpoints

Tue, 02/18/20 - 10:25 am

Pages